Back to Journals » International Journal of Nanomedicine » Volume 10 » Issue 1

Chitosan–tripolyphosphate nanoparticles as Arrabidaea chica standardized extract carrier: synthesis, characterization, biocompatibility, and antiulcerogenic activity

Authors Servat-Medina L, González-Gómez A, Reyes-Ortega F, Sousa IMO, Queiroz NDCA, Zago PMW, Jorge MP, Monteiro KM, de Carvalho JE, San Román J, Foglio MA

Received 28 February 2015

Accepted for publication 16 April 2015

Published 9 June 2015 Volume 2015:10(1) Pages 3897—3909

DOI https://doi.org/10.2147/IJN.S83705

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 4

Editor who approved publication: Prof. Dr. Thomas J Webster


Leila Servat-Medina,1,2 Alvaro González-Gómez,2,3 Felisa Reyes-Ortega,2 Ilza Maria Oliveira Sousa,1 Nubia de Cássia Almeida Queiroz,1 Patricia Maria Wiziack Zago,1 Michelle Pedrosa Jorge,1 Karin Maia Monteiro,1,4 João Ernesto de Carvalho,1 Julio San Román,2,3 Mary Ann Foglio1

1Chemical, Biological and Agricultural Pluridisciplinary Research Center-State University of Campinas (CPQBA-UNICAMP), Campinas-SP, Brazil; 2Biomaterials Group, Polymer Science and Technology Institute-Spanish National Research Council (ICTP-CSIC), 3CIBER-BBN, Centro de Investigación Biomédica en Red, Madrid, Spain; 4Department of Medical Clinics, Faculty of Medical Sciences, University of Campinas, Campinas-SP, Brazil

Abstract: Natural products using plants have received considerable attention because of their potential to treat various diseases. Arrabidaea chica (Humb. & Bonpl.) B. Verlot is a native tropical American vine with healing properties employed in folk medicine for wound healing, inflammation, and gastrointestinal colic. Applying nanotechnology to plant extracts has revealed an advantageous strategy for herbal drugs considering the numerous features that nanostructured systems offer, including solubility, bioavailability, and pharmacological activity enhancement. The present study reports the preparation and characterization of chitosan–sodium tripolyphosphate nanoparticles (NPs) charged with A. chica standardized extract (AcE). Particle size and zeta potential were measured using a Zetasizer Nano ZS. The NP morphological characteristics were observed using scanning electron microscopy. Our studies indicated that the chitosan/sodium tripolyphosphate mass ratio of 5 and volume ratio of 10 were found to be the best condition to achieve the lowest NP sizes, with an average hydrodynamic diameter of 150±13 nm and a zeta potential of +45±2 mV. Particle size decreased with AcE addition (60±10.2 nm), suggesting an interaction between the extract’s composition and polymers. The NP biocompatibility was evaluated using human skin fibroblasts. AcE-NP demonstrated capability of maintaining cell viability at the lowest concentrations tested, stimulating cell proliferation at higher concentrations. Antiulcerogenic activity of AcE-NP was also evaluated with an acute gastric ulcer experimental model induced by ethanol and indomethacin. NPs loaded with A. chica extract reduced the ulcerative lesion index using lower doses compared with the free extract, suggesting that extract encapsulation in chitosan NPs allowed for a dose reduction for a gastroprotective effect. The AcE encapsulation offers an approach for further application of the A. chica extract that could be considered a potential candidate for ulcer-healing pharmaceutical systems.

Keywords: natural product, Arrabidaea chica, chitosan, nanoparticle, plant extract, herbal drug, ulcer healing

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]